GHP NewsLatest Science mRNA as a critical area for pharma innovation The value of mRNA licensing agreements has skyrocketed by a staggering 800% between 2019 and 2024, driven by the success of mRNA-based COVID-19 vaccines and growing confidence in the technology’s broader... 18 October, 20243 min read